Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reuse 510(k)s Should Be Required For Class I Forceps - Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

FDA should remove the current exemption from premarket notification requirements for reprocessors of single use non-electric biopsy forceps, Boston Scientific maintains in a citizen petition filed by the agency Sept. 27.

You may also be interested in...



General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA

Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.

General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA

Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.

FDA's Premarket Policy For Device Reprocessors Questioned By Congressmen

FDA review standards for premarket applications submitted by reprocessors of single-use devices (SUDs) must be clarified to address the issue of one-time reuse versus multiple reuse, House Commerce Committee Chair Thomas Bliley (R-Va.) and Oversight and Investigations Subcommittee Chair Fred Upton (R-Mich.) maintain in a Nov. 1 letter to the agency.

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel